ArticleAdvances in urology2011

Clinical feature of men who benefit from dose escalation of naftopidil for lower urinary tract symptoms: a prospective study.

Takaki Mizusawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.